The utility of human papillomavirus testing in the management of atypical glandular cells on cytology

Journal of Lower Genital Tract Disease

Volumn 13, Issue 2, 2009, Pages 72-78

  Sharpless, Kathryn E ^a   O'Sullivan, David M ^b   Schnatz, Peter F ^b,c  

^a BAYSTATE MEDICAL CENTER   (United States)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Atypical glandular cells (AGCs); Cytology and dysplasia; Diagnostic techniques and procedures; Human papillomavirus; Pap smear and cervical cancer screening

Indexed keywords

ARTICLE; ATYPICAL GLANDULAR CELL; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; ENDOMETRIAL DISEASE; ENDOMETRIUM CELL; HUMAN; INFORMATION RETRIEVAL; META ANALYSIS; PREDICTOR VARIABLE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS EXAMINATION; WART VIRUS; FEMALE; PATIENT SELECTION; PREDICTION AND FORECASTING; REVIEW; RISK FACTOR; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 67650727389     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e318183bb0e     Document Type: Article

References (20)

1. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda system terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
2. Cangiarella JF, Chhieng DC. Atypical glandular cells - an update. Diagn Cytopathol 2003;29:371-379
3. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107:701-708 (Pubitemid 43755628)
4. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 Consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-222
5. ACOG Practice Bulletin. Management of abnormal cervical cytology and histology. American College of Obstetricians and Gynecologists Practice Bulletin No. 66, September 2005. Obstet Gynecol 2005;106:645-664
6. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Am J Clin Pathol 2004;121:87-92.
7. Carozzi FM, Confortini M, Cecchini S, Bisanzi S, Cariaggi MP, Pontenani G, et al. Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment. Cancer Cytopathol 2004;105:2-7.
8. Fetterman B, Shaber R, Pawlick G, Kinney W. Human papillomavirus DNA testing in routine clinical practice for prediction of underlying cervical intraepithelial neoplasia 2,3+ at initial evaluation and in follow-up of women with atypical glandular cell Papanicolaou tests (abstract). J Low Genit Tract Dis 2006;10:178-179
9. Jacobson RG, Lapinski RH, Kalir T. The clinical importance of atypical glandular cells of undetermined significance on the cytologic smear. Prim Care Update Ob/Gyns 2000;7:250-252 (Pubitemid 30833200)
10. Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, de Oliveira Zambeli ER, do Amaral Westin MC, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their pap smears. Gynecol Oncol 2004;95:618-623
11. Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol 2007;104:366-371
12. De Oliveira ERZM, Derchain SFM, Sarian LOZ, Rabelo-Santos SH, Gontijo RC, Yoshida A, et al. Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities. Int J Gynecol Cancer 2006;16:1055-1062 (Pubitemid 43886726)
13. Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, et al. High-risk human papillomavirus testing: a marker for atypical glandular cells. Diagn Cytopathol 2006;34:235-239
14. Irvin W, Evans SR, Andersen W, Jazaeri A, Taylor P, Stoler M, et al. The utility of HPV DNA triage in the management of cytological AGC. Am J Obstet Gynecol 2005;193:559-565 (Pubitemid 41159556)
15. Chen SF, Yang SF, Chu TY, Lai HC, Lin YW, Bai CY, et al. Which test is a better strategy to determine the outcome of atypical glandular cell-categorized Pap smears? Immunocytochemical p16INK4A expression or human papillomavirus test-a restrospective cohort study. Gynecol Oncol 2005;99:578-584
16. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significant (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-825
17. Schnatz PF, Sharpless KE, O'Sullivan DM. Use of human papillomavirus testing in the management of atypical glandular cells. J Lower Genit Tract Dis. 2009;13:94-101.
18. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108;264-272
19. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129 (Pubitemid 34437347)
20. Sharpless KE, Schnatz PE, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:494-500. (Pubitemid 40271212)